April 6, 2017 / 7:25 AM / 8 months ago

BRIEF-Cipla U.S. arm signs worldwide licensing deal with MEDRx

April 6 (Reuters) - Cipla Ltd

* Says Cipla USA enters into collaboration with Medrx

* Medrx is eligible to receive up to USD 30 million cumulatively through upfront and developmental, regulatory, and commercial milestones payments

* Medrx will also receive tiered royalties on the net sales of commercialized licensed products

* Worldwide licensing agreement (except for east asia) signed for development, commercialize of mrx-4tzt, a tizanidine1 patch for spasticity Source text: bit.ly/2ne6obe Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below